This was in reference to a bribery grievance filed by the Lilavati Kirtilal Mehta Medical Belief, which runs Lilavati Hospital in Mumbai. Shares of HDFC Bank Ltd ended at ₹772.55, down by ₹5.35, or 0.69%, on the BSE at present, Might 5.
1 Min Learn
The Bombay Excessive Court docket on Tuesday (Might 5) quashed the primary data report (FIR) registered against HDFC Bank Ltd Managing Director and CEO Sashidhar Jagdishan in reference to a bribery grievance filed by the Lilavati Kirtilal Mehta Medical Belief, which runs Lilavati Hospital in Mumbai.
A division Bench of Justices MS Karnik and NR Borkar allowed Jagdishan’s plea in search of quashing of the FIR and likewise put aside the Justice of the Peace courtroom’s Might 29 order directing a police probe into the matter. The courtroom, whereas granting reduction, noticed that the grievance was “non-bona fide” and quashed the case registered against the financial institution chief.
The FIR was lodged on a grievance by the Lilavati Kirtilal Mehta Medical Belief by its authorised consultant and trustee, Prashant Kishor Mehta. The allegations claimed that Jagdishan had accepted a bribe of ₹2.05 crore to help a gaggle comprising Chetan Mehta and different former trustees in allegedly retaining unlawful management over the belief that manages the hospital.
ALSO READ | HDFC Bank shares are actually a ‘consensus purchase’ amongst all 47 analysts after This autumn outcomes
Shares of HDFC Bank Ltd ended at ₹772.55, down by ₹5.35, or 0.69%, on the BSE at present, Might 5.
(Edited by : Shoma Bhattacharjee)
First Revealed: Might 5, 2026 5:25 PM IST
Source link
#Bombay #quashes #2crore #bribery #FIR #HDFC #Bank #CEO #Sashidhar #Jagdishan #CNBC #TV18
